89bio, Inc. (ETNB)
NASDAQ: ETNB · Real-Time Price · USD
6.07
+0.18 (2.97%)
Apr 17, 2025, 4:00 PM EDT - Market closed
89bio Stock Forecast
Stock Price Forecast
The 9 analysts with 12-month price forecasts for 89bio stock have an average target of 27.56, with a low estimate of 11 and a high estimate of 49. The average target predicts an increase of 354.41% from the current stock price of 6.07.
Analyst Consensus: Strong Buy
* Price targets were last updated on Mar 14, 2025.
Analyst Ratings
The average analyst rating for 89bio stock from 10 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 4 | 4 | 5 | 5 |
| Buy | 2 | 2 | 2 | 3 | 3 | 3 |
| Hold | 2 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 8 | 9 | 10 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Goldman Sachs | Goldman Sachs | Hold Initiates $11 | Hold | Initiates | $11 | +81.37% | Mar 14, 2025 |
| Citigroup | Citigroup | Strong Buy Initiates $25 | Strong Buy | Initiates | $25 | +312.20% | Mar 13, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $29 → $21 | Strong Buy | Reiterates | $29 → $21 | +246.25% | Feb 28, 2025 |
| Wolfe Research | Wolfe Research | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Feb 4, 2025 |
| UBS | UBS | Strong Buy Maintains $25 → $38 | Strong Buy | Maintains | $25 → $38 | +526.55% | Jan 31, 2025 |
Financial Forecast
Revenue This Year
n/a
from 847.98M
Revenue Next Year
n/a
EPS This Year
-1.99
from -3.51
EPS Next Year
-2.06
from -1.99
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | n/a | 26.3M | 98.7M | ||
| Avg | n/a | 6.6M | 38.0M | ||
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | 1,398.6% | ||
| Avg | - | - | 477.0% | ||
| Low | - | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -1.67 | -1.43 | -1.49 | ||
| Avg | -1.99 | -2.06 | -1.99 | ||
| Low | -2.28 | -2.45 | -2.70 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.